Trial Profile
Special Drug Use Surveillance of LIXIANA Tablet - Long-term use in patients with venous thromboembolism -
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2019
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms ETNA-VTE-Japan
- Sponsors Daiichi Sankyo Company
- 04 Oct 2019 Status changed from active, no longer recruiting to completed.
- 10 May 2019 Results of interim analysis of data collected at 3 months published in the Circulation Journal
- 02 Aug 2017 Status changed from recruiting to active, no longer recruiting.